Each year, synthetic opioids like fentanyl contribute to the deaths of 100,000 Americans from overdoses, making it a major public health concern.
While naloxone is currently used as an antidote for opiate overdose, it is less effective against potent synthetic opioids such as fentanyl.
However, researchers at Indiana University have made a significant breakthrough by identifying a new approach to reverse the effects of fentanyl.
Their findings, published in the Journal of Medicinal Chemistry, could potentially lead to the development of a new product or a combined treatment involving naloxone.
Fentanyl, known to be 50 to 100 times stronger than morphine, tightly binds to opioid receptors in the central nervous system.
Naloxone, which is used to counteract opioid overdoses, competes with opioids for the same binding site. However, during a fentanyl overdose, naloxone and fentanyl bind to different sites, eliminating the competition.
To address this challenge, the researchers explored the use of a negative allosteric modulator to reverse the effects of fentanyl.
The senior research scientist for the Gill Center for Biomolecular Science, Alex Straiker, initiated the study by examining the impact of opioid receptors on a signaling molecule called cAMP.
Through chemical testing of 50 structurally related compounds, the researchers identified those that demonstrated the most potential as effective negative allosteric modulators.
Interestingly, they found that cannabidiol (CBD), a compound derived from cannabis, could act as a negative allosteric modulator at the binding site. However, high concentrations of CBD were initially required for its effectiveness.
To enhance its potency, the researchers modified the structure of cannabidiol and discovered that it successfully reversed the effects of fentanyl in in vitro diagnostics, which involve tests conducted on blood or tissue samples.
“We’ve identified specific structural components that are crucial for achieving the desired antidote effect,” explains Straiker.
“Some of these compounds are even more powerful than the initial lead compound. We’ve collaborated with another research team to model the binding site, which may help identify additional compounds for further exploration.”
The next crucial step is to test the effectiveness of these findings in vivo, meaning on living organisms, to determine if the modified cannabidiol can reverse the respiratory depression, which is the primary effect of fentanyl overdose.
This groundbreaking research offers hope in combating the devastating impact of fentanyl overdoses.
If proven successful in future studies, this method could potentially save countless lives by providing an additional weapon against the powerful grip of synthetic opioids.
Follow us on Twitter for more articles about this topic.
